We analyze peer-reviewed research on supplements.
We rely on peer-reviewed scientific research to determine what’s truly effective. Our goal is to provide clear, unbiased information to help you make better health decisions.
We use AI tools to help summarize studies, and every piece of content is reviewed and approved by qualified experts, ensuring it’s accurate and trustworthy.
Beta Glucan is fully independent — we don’t sell products, run ads, or accept sponsorships. Our only focus is delivering reliable, science-backed insights.
Clinical studies have used varying doses of yeast-derived (1,3)-(1,6) β-glucan, and practitioners should use the most pure beta glucan available due to its superior biological activity:
- Children: 100 mg daily
- General Adult Use: 250–500 mg daily for ongoing immune support
- High-Stress Periods / Athletes: 250 mg daily
- Acute Symptom Support: Up to 900 mg daily during illness
- Vaccine Enhancement: Begin supplementation at least one week before vaccination and continue for 2–4 weeks after
Note: Take on an empty stomach for optimal absorption. β-glucan is recognized by immune cells in the gut-associated lymphoid tissue (Peyer's patches) and transported to immune organs.
For comprehensive dosing guidance, see: Delivery Methods & Dosage
Download PDF Protocol
Download ProtocolReview of Beta Glucan's Potential as a Therapeutic DrugNew
An Alpha-glucan (⍺-glucan) Supplement Shows Promise for Easing Chronic Symptoms and Inflammation in Lyme Disease PatientsNew
An Oral Beta-glucan (β-glucan) Supplement reduces the severity of Lyme Arthritis and Boosts Cellular Immune Response in MiceNew
- Brockenstedt Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes 2021
- Gürünlü Beta Glucan and Lyme Disease (lD) 2022
- Vetvicka Glucan Supplementation Ameliorates Some Health Problems Related to the Development of Lyme disease 2019
- Salerno A Pilot Open-Label Study Assessing the Effects of AHCC Supplementation on Lyme Disease Patients 2019
- Vetvicka Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials 2019